Skip to main content
Top
Published in: Gut Pathogens 1/2021

Open Access 01-12-2021 | Esophageal Cancer | Case report

Cytomegalovirus‐associated esophagitis on early esophageal cancer in immunocompetent host: a case report

Authors: Daisuke Murakami, Hideaki Harada, Masayuki Yamato, Yuji Amano

Published in: Gut Pathogens | Issue 1/2021

Login to get access

Abstract

Background

Cytomegalovirus (CMV)-associated gastrointestinal diseases usually occur in immunocompromised patients; however, few cases has also been described in healthy hosts despite still unclear pathological mechanisms. CMV esophagitis causes various lesions, such as erythematous mucosa, erosions, and ulcers, although such inflammatory changes can appear in superficial esophageal cancers or in surrounding areas. CMV-associated esophagitis has been also reported in cancer patients, but typically in those with advanced and/or terminal stage cancers secondary to chemoradiotherapy-induced immunosuppression or the physiologic demands of the malignancy itself. To our best knowledge, we firstly report on an immunocompetent patient subject to endoscopic submucosal dissection (ESD) for early esophageal cancer complicated with CMV infection.

Case presentation

A 77-year-old man underwent esophagogastroduodenoscopy (EGD) at a local clinic. EGD revealed a lugol-unstained reddish lesion with whitish exudates in the middle-distal esophagus. Histological evaluation of lesion biopsy revealed atypical squamous epithelium with CMV-positive granulation tissue and aggregates of macrophages, prompting referral for further examination and treatment. Magnifying endoscopy with narrow-band imaging showed an erosive lesion with white moss in a well-demarcated brownish area with irregular mesh-like microvessels. ESD was performed for diagnosis and treatment. Histopathological examination of the resected specimen revealed superficial, moderately differentiated squamous cell carcinoma (SCC) with multiple lymphatic infiltration, and few CMV-positive cells were found in the erosive part of the SCC. Interestingly, he had no underlying conditions to predispose to CMV infection and no risk factors for esophageal cancer, other than gender and age. He received neither steroids for stricture prevention nor antiviral agents post-EGD and 4-month follow-up was negative for esophagitis.

Conclusions

This is the first report of a case of CMV esophagitis superimposed on early esophageal cancer in an immunocompetent host and might provide valuable information for possible adverse effects of steroid administration during ESD procedures, despite their common use for prevention of post-ESD stricture.
Literature
1.
go back to reference Rafailidis PI, Mourtzoukou EG, Varbobitis IC, Falagas ME. Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review. Virol J. 2008;5:47.CrossRef Rafailidis PI, Mourtzoukou EG, Varbobitis IC, Falagas ME. Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review. Virol J. 2008;5:47.CrossRef
2.
go back to reference Grundy JE. Virologic and pathogenetic aspects of cytomegalovirus infection. Rev Infect Dis. 1990;12:701–10.CrossRef Grundy JE. Virologic and pathogenetic aspects of cytomegalovirus infection. Rev Infect Dis. 1990;12:701–10.CrossRef
3.
go back to reference Bernard S, Germi R, Lupo J, Laverrière MH, Masse V, Morand P, et al. Symptomatic cytomegalovirus gastrointestinal infection with positive quantitative real-time PCR findings in apparently immunocompetent patients: a case series. Clin Microbiol Infect. 2015;21:1121.CrossRef Bernard S, Germi R, Lupo J, Laverrière MH, Masse V, Morand P, et al. Symptomatic cytomegalovirus gastrointestinal infection with positive quantitative real-time PCR findings in apparently immunocompetent patients: a case series. Clin Microbiol Infect. 2015;21:1121.CrossRef
4.
go back to reference Wilcox CM, Diehl DL, Cello JP. Cytomegalovirus esophagitis in patients with AIDS. A clinical, endoscopic, and pathologic correlation. Ann Intern Med. 1990;113:589–93.CrossRef Wilcox CM, Diehl DL, Cello JP. Cytomegalovirus esophagitis in patients with AIDS. A clinical, endoscopic, and pathologic correlation. Ann Intern Med. 1990;113:589–93.CrossRef
5.
go back to reference Venkataramani A, Schlueter AJ, Spech TJ, Greenberg E. Cytomegalovirus esophagitis in an immunocompetent host. Gastrointest Endosc. 1994;40:392–3.CrossRef Venkataramani A, Schlueter AJ, Spech TJ, Greenberg E. Cytomegalovirus esophagitis in an immunocompetent host. Gastrointest Endosc. 1994;40:392–3.CrossRef
6.
go back to reference Maiorana A, Baccarini P, Foroni M, Bellini N, Giusti F. Human cytomegalovirus infection of the gastrointestinal tract in apparently immunocompetent patients. Hum Pathol. 2003;34:1331–6.CrossRef Maiorana A, Baccarini P, Foroni M, Bellini N, Giusti F. Human cytomegalovirus infection of the gastrointestinal tract in apparently immunocompetent patients. Hum Pathol. 2003;34:1331–6.CrossRef
7.
go back to reference Wang HW, Kuo CJ, Lin WR, Hsu CM, Ho YP, Lin CJ, et al. The clinical characteristics and manifestations of cytomegalovirus esophagitis. Dis Esophagus. 2015;29:392–9.CrossRef Wang HW, Kuo CJ, Lin WR, Hsu CM, Ho YP, Lin CJ, et al. The clinical characteristics and manifestations of cytomegalovirus esophagitis. Dis Esophagus. 2015;29:392–9.CrossRef
8.
go back to reference Ohnuma H, Sato Y, Takayama T, Takayama Y, Takimoto R, Abe T, et al. Esophageal cancer complicated by cytomegalovirus esophagitis during chemoradiotherapy: case report. Gastrointest Endosc. 2003;57:622–6.CrossRef Ohnuma H, Sato Y, Takayama T, Takayama Y, Takimoto R, Abe T, et al. Esophageal cancer complicated by cytomegalovirus esophagitis during chemoradiotherapy: case report. Gastrointest Endosc. 2003;57:622–6.CrossRef
9.
go back to reference Matsuda Y, Kishida S, Miyamoto H, Lee S, Okawa M, Fujiwara Y, et al. Cytomegalovirus-associated ulceration of gastric conduit after chemoradiotherapy following esophagectomy for cancer. Esophagus. 2015;12:300–3.CrossRef Matsuda Y, Kishida S, Miyamoto H, Lee S, Okawa M, Fujiwara Y, et al. Cytomegalovirus-associated ulceration of gastric conduit after chemoradiotherapy following esophagectomy for cancer. Esophagus. 2015;12:300–3.CrossRef
10.
go back to reference Yamamoto Y, Kikuchi D, Nagami Y, Nonaka K, Tsuji Y, Fujimoto A, et al. Management of adverse events related to endoscopic resection of upper gastrointestinal neoplasms: review of the literature and recommendations from experts. Dig Endosc. 2019;1:4–20.CrossRef Yamamoto Y, Kikuchi D, Nagami Y, Nonaka K, Tsuji Y, Fujimoto A, et al. Management of adverse events related to endoscopic resection of upper gastrointestinal neoplasms: review of the literature and recommendations from experts. Dig Endosc. 2019;1:4–20.CrossRef
11.
go back to reference Topalian SL, Hodi FS, Brahmer, Gettinger SN, Smith DC, McDermott DF, et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med. 2012;366:2443–54.CrossRef Topalian SL, Hodi FS, Brahmer, Gettinger SN, Smith DC, McDermott DF, et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med. 2012;366:2443–54.CrossRef
12.
go back to reference Goda K, Irisawa A. Japan Esophageal Society classification for predicting the invasion depth of superficial esophageal squamous cell carcinoma: should it be modified now? Dig Endosc. 2020;32:37–8.CrossRef Goda K, Irisawa A. Japan Esophageal Society classification for predicting the invasion depth of superficial esophageal squamous cell carcinoma: should it be modified now? Dig Endosc. 2020;32:37–8.CrossRef
13.
go back to reference Marques S, Carmo J, Pinto D, Bispo M, Sância Ramos S, Chagasa C. Cytomegalovirus disease of the upper gastrointestinal tract: a 10-year retrospective study. GE Port J Gastroenterol. 2017;24:262–8.CrossRef Marques S, Carmo J, Pinto D, Bispo M, Sância Ramos S, Chagasa C. Cytomegalovirus disease of the upper gastrointestinal tract: a 10-year retrospective study. GE Port J Gastroenterol. 2017;24:262–8.CrossRef
14.
go back to reference Michaelis M, Doerr HW, Cinatl J. The story of human cytomegalovirus and cancer: increasing evidence and open questions. Neoplasia. 2009;11:1–9.CrossRef Michaelis M, Doerr HW, Cinatl J. The story of human cytomegalovirus and cancer: increasing evidence and open questions. Neoplasia. 2009;11:1–9.CrossRef
15.
go back to reference Harkins L, Volk AL, Samanta M, Mikolaenko I, Britt WJ, Bland KI, et al. Specific localization of human cytomegalovirus nucleic acids and proteins in human colorectal cancer. Lancet. 2002;360:1557–63.CrossRef Harkins L, Volk AL, Samanta M, Mikolaenko I, Britt WJ, Bland KI, et al. Specific localization of human cytomegalovirus nucleic acids and proteins in human colorectal cancer. Lancet. 2002;360:1557–63.CrossRef
16.
go back to reference Chen HP, Jiang JK, Chen CY, Chou TY, Chen YC, Chang YT, et al. Human cytomegalovirus preferentially infects the neoplastic epithelium of colorectal cancer: a quantitative and histological analysis. J Clin Virol. 2012;54:240–4.CrossRef Chen HP, Jiang JK, Chen CY, Chou TY, Chen YC, Chang YT, et al. Human cytomegalovirus preferentially infects the neoplastic epithelium of colorectal cancer: a quantitative and histological analysis. J Clin Virol. 2012;54:240–4.CrossRef
17.
go back to reference Shoji H, Yamaguchi N, Isomoto H, Minami H, Matsushima K, Akazawa Y, et al. Oral prednisolone and triamcinolone injection for gastric stricture after endoscopic submucosal dissection. Ann Transl Med. 2014;2:22.PubMedPubMedCentral Shoji H, Yamaguchi N, Isomoto H, Minami H, Matsushima K, Akazawa Y, et al. Oral prednisolone and triamcinolone injection for gastric stricture after endoscopic submucosal dissection. Ann Transl Med. 2014;2:22.PubMedPubMedCentral
18.
go back to reference Ohki T, Yamato M, Ota M, Takagi R, Murakami D, Kondo M, et al. Prevention of esophageal stricture after endoscopic submucosal dissection using tissue-engineered cell sheets. Gastroenterology. 2012;143:582–8.CrossRef Ohki T, Yamato M, Ota M, Takagi R, Murakami D, Kondo M, et al. Prevention of esophageal stricture after endoscopic submucosal dissection using tissue-engineered cell sheets. Gastroenterology. 2012;143:582–8.CrossRef
19.
go back to reference Saito Y, Tanaka T, Andoh A, Minematsu H, Hata K, Tsujikawa T, et al. Novel biodegradable stents for benign esophageal strictures following endoscopic submucosal dissection. Dig Dis Sci. 2008;53:330–3.CrossRef Saito Y, Tanaka T, Andoh A, Minematsu H, Hata K, Tsujikawa T, et al. Novel biodegradable stents for benign esophageal strictures following endoscopic submucosal dissection. Dig Dis Sci. 2008;53:330–3.CrossRef
20.
go back to reference Muto M, Ezoe Y, Yano T, Aoyama I, Yoda Y, Minashi K, et al. Usefulness of endoscopic radial incision and cutting method for refractory esophagogastric anastomotic stricture (with video). Gastrointest Endosc. 2012;75:965–72.CrossRef Muto M, Ezoe Y, Yano T, Aoyama I, Yoda Y, Minashi K, et al. Usefulness of endoscopic radial incision and cutting method for refractory esophagogastric anastomotic stricture (with video). Gastrointest Endosc. 2012;75:965–72.CrossRef
21.
go back to reference Chalasani N, Parker KM, Wilcox CM. Bronchoesophageal fistula as a complication of cytomegalovirus esophagitis in AIDS. Endoscopy. 1997;29:28–9.CrossRef Chalasani N, Parker KM, Wilcox CM. Bronchoesophageal fistula as a complication of cytomegalovirus esophagitis in AIDS. Endoscopy. 1997;29:28–9.CrossRef
22.
go back to reference Olmos M, Sanchez-Basso A, Battaglia M, Concetti H, Magnanini F. Esophageal strictures complicating cytomegalovirus ulcers in patients with AIDS. Endoscopy. 2001;33:822.CrossRef Olmos M, Sanchez-Basso A, Battaglia M, Concetti H, Magnanini F. Esophageal strictures complicating cytomegalovirus ulcers in patients with AIDS. Endoscopy. 2001;33:822.CrossRef
23.
go back to reference Soroceanu L, Akhavan A, Cobbs CS. Platelet-derived growth factor-alpha receptor activation is required for human cytomegalovirus infection. Nature. 2008;455:391–5.CrossRef Soroceanu L, Akhavan A, Cobbs CS. Platelet-derived growth factor-alpha receptor activation is required for human cytomegalovirus infection. Nature. 2008;455:391–5.CrossRef
24.
go back to reference Schlick K, Grundbichler M, Auberger J, Kern JM, Hell M, Hohla F, et al. Cytomegalovirus reactivation and its clinical impact in patients with solid tumors. Infect Agent Cancer. 2015;10:45.CrossRef Schlick K, Grundbichler M, Auberger J, Kern JM, Hell M, Hohla F, et al. Cytomegalovirus reactivation and its clinical impact in patients with solid tumors. Infect Agent Cancer. 2015;10:45.CrossRef
25.
go back to reference Nagata N, Kobayakawa M, Shinbo T, Hoshimoto K, Yada T, Gotoda T, et al. Diagnostic value of antigenemia assay for cytomegalovirus gastrointestinal disease in immunocompromised patients. World J Gastroenterol. 2011;17:1185–91.CrossRef Nagata N, Kobayakawa M, Shinbo T, Hoshimoto K, Yada T, Gotoda T, et al. Diagnostic value of antigenemia assay for cytomegalovirus gastrointestinal disease in immunocompromised patients. World J Gastroenterol. 2011;17:1185–91.CrossRef
26.
go back to reference Villanueva F, Yuan C, Drane W, Dang L, Nguyen TC. Cancer treatment response to checkpoint inhibitors is associated with cytomegalovirus infection. Cureus. 2020;12:e6670.PubMedPubMedCentral Villanueva F, Yuan C, Drane W, Dang L, Nguyen TC. Cancer treatment response to checkpoint inhibitors is associated with cytomegalovirus infection. Cureus. 2020;12:e6670.PubMedPubMedCentral
27.
go back to reference Erkes DA, Smith CJ, Wilski NA, Caldeira-Dantas S, Mohgbeli T, Snyder CM. Virus-specific CD8+ T cells infiltrate melanoma lesions and retain function independently of PD-1 expression. J Immunol. 2017;198:2979–88.CrossRef Erkes DA, Smith CJ, Wilski NA, Caldeira-Dantas S, Mohgbeli T, Snyder CM. Virus-specific CD8+ T cells infiltrate melanoma lesions and retain function independently of PD-1 expression. J Immunol. 2017;198:2979–88.CrossRef
28.
go back to reference Erkes DA, Wilski NA, Snyder CM. Intratumoral infection by CMV may change the tumor environment by directly interacting with tumor-associated macrophages to promote cancer immunity. Hum Vaccines Immunother. 2017;13:1778–85.CrossRef Erkes DA, Wilski NA, Snyder CM. Intratumoral infection by CMV may change the tumor environment by directly interacting with tumor-associated macrophages to promote cancer immunity. Hum Vaccines Immunother. 2017;13:1778–85.CrossRef
29.
go back to reference Quinn M, Erkes DA, Snyder CM. Cytomegalovirus and immunotherapy: opportunistic pathogen, novel target for cancer and a promising vaccine vector. Immunotherapy. 2016;8:211–21.CrossRef Quinn M, Erkes DA, Snyder CM. Cytomegalovirus and immunotherapy: opportunistic pathogen, novel target for cancer and a promising vaccine vector. Immunotherapy. 2016;8:211–21.CrossRef
30.
go back to reference Kato K, Cho BC, Takahashi M, Okada M, Lin CY, Chin K, et al. Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2019;20:1506–13.CrossRef Kato K, Cho BC, Takahashi M, Okada M, Lin CY, Chin K, et al. Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2019;20:1506–13.CrossRef
Metadata
Title
Cytomegalovirus‐associated esophagitis on early esophageal cancer in immunocompetent host: a case report
Authors
Daisuke Murakami
Hideaki Harada
Masayuki Yamato
Yuji Amano
Publication date
01-12-2021
Publisher
BioMed Central
Published in
Gut Pathogens / Issue 1/2021
Electronic ISSN: 1757-4749
DOI
https://doi.org/10.1186/s13099-021-00418-4

Other articles of this Issue 1/2021

Gut Pathogens 1/2021 Go to the issue